Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...
Here we go again. From the New York Health Department: Anyone Who Ate Food From ilili Restaurant During January 31 – February ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
CHARLESTON, W.Va. — West Virginia senators voted to dismantle one of the nation’s strictest school vaccination policies Friday by greenlighting an exemption for families who say mandated inoculations ...
The grocery store chain Trader Joe’s has recalled a popular frozen breakfast item over fears of contamination. Trader Joe’s ...
The Company plans to file a Form 25 with the Securities and Exchange Commission (SEC) on March 15, 2025, initiating the delisting process. The delisting is expected to become effective ten days after ...
Citizens JMP raised the firm’s price target on Dynavax (DVAX) to $33 from $29 and keeps an Outperform rating on the shares. Dynavax reported ...
Every day, hospitals throughout the U.S. transfuse blood or blood components, such as platelets, to save the lives of people who are in car crashes, and victims of fires and other emergencies.
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...
Hepatitis is a medical condition defined by inflammation of the liver. It can be caused by infection of the liver by hepatitis viruses (hepatitis B, hepatitis C and viral hepatitis) or is of ...
In certain communities along the East Coast, the mere mention of the name “Wawa” conjures up visions of piping-hot coffee, scratch-off lottery tickets and pre-made Sizzli breakfast sandwiches. But ...
The mouse on the right with four times the normal muscle mass is placed with a normal mouse. Handout via REUTERS About a dozen drugmakers are developing new weight-loss treatments aimed at ...